CV Lattes
Secretaria de Desenvolvimento Econômico (São Paulo - Estado). Instituto de Pesquisas Energéticas e Nucleares (IPEN) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduation at Engenharia Química from Universidade Federal da Paraíba (2014) and master's at Nuclear Engineering from Universidade de São Paulo (2017). , acting on the following subjects: bacillus sp., celulases, enzimas, engenharia bioquímica and celulase. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
iN 1986, Interferon was the first drug to demonstrate beneficial effects in patients with hepatitis C. Currently, all of hepatitis C treatments are based on the use of combined preparations of IFN-± with or without ribavirin. The therapy results in rapid decline of hepatitis C virus levels in the serum and, in long term, its extinction occurs in blood and liver. The alpha-2 interferon (IF…
| 1 / 1 | Completed scholarships in Brazil |
| Associated processes | |